• 1. An ATP-selective, lanthanide complex luminescent probe?
  Xiao Liu,Jun Xu,Yinyun Lv,Wenyu Wu,Weisheng Liu,Yu Tang Dalton Trans., 2013,42, 9840-9846
• 2. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 3. Aggregation dynamics, structure, and mechanical properties of bigels
  L. Di Michele,D. Fiocco,F. Varrato,E. Eiser,G. Foffi Soft Matter, 2014,10, 3633-3648
• 4. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 5. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829

Introduction to 2,4,5-Trifluorobenzamidine hydrochloride (CAS No. 764648-43-3)

2,4,5-Trifluorobenzamidine hydrochloride, with the chemical identifier CAS No. 764648-43-3, is a fluorinated benzamidine derivative that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to a class of molecules characterized by the presence of multiple fluorine atoms, which confer unique electronic and steric properties, making it a valuable scaffold for the development of novel bioactive agents.

The structural motif of 2,4,5-Trifluorobenzamidine hydrochloride consists of a benzene ring substituted with three fluorine atoms at the 2, 4, and 5 positions, linked to an amidine group. The hydrochloride salt form enhances its solubility in aqueous media, facilitating its use in various biochemical and pharmacological assays. The compound’s ability to interact with biological targets through hydrogen bonding and electrostatic interactions has been leveraged in the design of inhibitors targeting enzymes involved in critical metabolic pathways.

In recent years, there has been growing interest in the development of fluorinated aromatic compounds due to their enhanced metabolic stability and improved binding affinity to biological targets. 2,4,5-Trifluorobenzamidine hydrochloride exemplifies this trend, as it has been investigated for its potential applications in drug discovery. Its fluorinated structure not only increases lipophilicity but also modulates electronic properties, allowing for fine-tuning of interactions with proteins and nucleic acids.

One of the most compelling aspects of 2,4,5-Trifluorobenzamidine hydrochloride is its utility as a building block for more complex molecules. Researchers have utilized this compound to synthesize derivatives with enhanced pharmacological properties. For instance, modifications at the amidine group have led to the development of potent inhibitors of matrix metalloproteinases (MMPs), which are enzymes implicated in various pathological processes such as cancer metastasis and inflammation.

The role of fluorine atoms in medicinal chemistry is well-documented, with their presence often leading to improved pharmacokinetic profiles. The introduction of fluorine at specific positions on the benzene ring in 2,4,5-Trifluorobenzamidine hydrochloride enhances its binding affinity to target enzymes by influencing both steric and electronic effects. This has been particularly relevant in the design of kinase inhibitors, where subtle modifications can significantly alter enzyme inhibition kinetics.

Recent studies have highlighted the potential of 2,4,5-Trifluorobenzamidine hydrochloride as an intermediate in the synthesis of antiviral agents. The compound’s ability to interfere with viral protease activity has been explored, particularly in the context of emerging infectious diseases. By targeting essential viral enzymes with high specificity, derivatives of this molecule have shown promise in preclinical models as candidates for therapeutic intervention.

The synthesis of 2,4,5-Trifluorobenzamidine hydrochloride involves multi-step organic transformations that highlight its synthetic versatility. The introduction of fluorine atoms typically requires specialized methodologies such as halogen exchange reactions or direct fluorination techniques. These synthetic strategies not only underscore the compound’s complexity but also demonstrate the advancements in fluorinated chemistry that have enabled its production at scale.

In conclusion,2,4,5-Trifluorobenzamidine hydrochloride (CAS No. 764648-43-3) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and biological relevance. Its role as a versatile intermediate and lead compound underscores its importance in drug discovery efforts aimed at addressing critical therapeutic challenges. As research continues to uncover new applications for this compound and its derivatives,2,4,5-Trifluorobenzamidine hydrochloride is poised to remain a cornerstone in medicinal biology and chemical pharmacology.

• 762229-49-2(2,6-difluoro-benzamidine)
• 504404-35-7(3,4,5-trifluorobenzene-1-carboximidamide)
• 71204-93-8(2-Fluorobenzamidine)
• 885957-28-8(2,5-Difluoro-benzamidine)
• 57075-81-7(2-fluorobenzene-1-carboximidamide hydrochloride)
• 304867-43-4(2,6-Difluorobenzenecarboximidamide Hydrochloride)
• 785754-37-2(3-fluoro-4-methylbenzene-1-carboximidamide)
• 885957-21-1(2,4-difluoro-benzamidine)
• 885957-09-5(2,3-difluorobenzene-1-carboximidamide)
• 885954-65-4(2,3,4-trifluorobenzene-1-carboximidamide)